Pharmacokinetic Properties of Cytokines in Their Targeted Delivery Based on Autologous Erythrocyte Pharmacocytes

INTRODUCTION: Using autologous erythrocytes as drug carriers for targeted delivery of cytokines to the sites of inflammation could potentially provide new opportunities for treatment of patients with purulent diseases. The targeted characteristic of erythrocytes is associated with the nature of puru...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhumadilov, Zhaxybay, Berikkhanova, Kulzhan, Gulyayev, Alexander, Shulgau, Zarina, Ibrasheva, Dilbar, Bokebaev, Zhanybek, Mussin, Nadiar, Nurgozhin, Talgat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University Library System, University of Pittsburgh 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960952/
https://www.ncbi.nlm.nih.gov/pubmed/29805913
http://dx.doi.org/10.5195/cajgh.2014.184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960952/
https://www.ncbi.nlm.nih.gov/pubmed/29805913
http://dx.doi.org/10.5195/cajgh.2014.184

Ejemplares similares